Gout

Jump to: navigation, search
Figure 1:Tophaceous gout affecting the right great toe and finger interphalangeal joints. Note the asymmetrical swelling and yellow-white discolouration.[1]


For patient information click here

Gout Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Gout from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gout On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gout

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gout

CDC on Gout

Gout in the news

Blogs on Gout

Directions to Hospitals Treating Gout

Risk calculators and risk factors for Gout

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Synonyms and Keywords: Urate crystal arthropathy; uric acid crystal deposition in joint; gouty arthritis; podagra

Overview

Historical Perspective

Pathophysiology

Differentiating Gout from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Clinical practice guidelines inform treatment[2].

Prognosis

Case Studies

Case #1

Related Chapter

External Links

  • "Answers and Questions on Gout". U.S. National Institutes of HealthNational Institute of Arthritis and Musculoskeletal and Skin Diseases. September 28th, 2007. Retrieved 2007-08-28. Check date values in: |date= (help)
  • "Coffee Consumption and Reduced Gout Risk". Drinking coffee reduces risk of gout in middle age men. U.S. National Institutes of Health. Retrieved 2007-05-25.

References

  1. Roddy, Edward (2011). "Revisiting the pathogenesis of podagra: why does gout target the foot?". Journal of Foot and Ankle Research. 4 (1). doi:10.1186/1757-1146-4-13. ISSN 1757-1146.
  2. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM; et al. (2020). "2020 American College of Rheumatology Guideline for the Management of Gout". Arthritis Rheumatol. 72 (6): 879–895. doi:10.1002/art.41247. PMID 32390306 Check |pmid= value (help).



ar:نقرس bg:Подагра cs:Dna da:Gigt de:Gicht eo:Podagro fa:نقرس io:Kiragro id:Gout it:Gotta he:שיגדון lb:Giicht ms:Gout nl:Jicht no:Urinsyregikt sk:Dna sr:Гихт fi:Kihti sv:Gikt te:గౌటు